BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30

• BioMidwest

  Surprise! Pfizer And Eli Lilly Were The Original Pot Sellers

  April 10, 2015

   · 

  1 min read
• 

  Genetown

  Death Possibly Linked to Biogen Tecfidera “No Cause for Alarm,” Says Analyst

  April 10, 2015

   · 

  3 min read
• 

  Pharm Country

  Fidelity CEO Uses Personal Fortune to Bet on Cancer Related IPOs Like Coherus, Adaptimmune and Blueprint Medicines

  April 10, 2015

   · 

  4 min read
• Policy

  New FDA Program Will Expedite Approval Of “Breakthrough” Medical Devices for Sickest Patients

  April 10, 2015

   · 

  1 min read
• Drug Development

  Roche Scientists Testing to See if Arthritis Blockbuster Will Work for Diabetes

  April 10, 2015

   · 

  1 min read
• Biotech Bay

  Can the Apple Smart Watch Really Keep the Doctor Away?

  April 10, 2015

   · 

  1 min read
• 

  Drug Development

  AstraZeneca PLC’s Diabetes Drug Onglyza May Increase Risk of Heart Failure, FDA Panel Reports

  April 10, 2015

   · 

  2 min read
• Business

  XO1 Deal Shows It Only Takes Two People To Run A Successful Biotech; Venture Capitalists Take Note

  April 10, 2015

   · 

  1 min read
• BioCapital

  The NIH Spends More On Paperwork Than Researching Hodgkin’s Disease

  April 10, 2015

   · 

  1 min read
• Genetown

  Seven Things to Take Away From “What’s Hot in Boston Biotech”

  April 10, 2015

   · 

  1 min read